Concord Biotech Limited
Share Price Target & Analysis
NSE:CONCORDBIO
VWAP
Open
Close
High
Low
52 Week High
-41.40 (-3.26%)
CONCORDBIO
(Miscellaneous)Turnaround Potential
52 Week Low
EPS
PE
PB
Economical
Quality
Gold
Valuation
#Analysis
NSE: CONCORDBIO Share Price Financial Analysis & Valuation
Concord Biotech Limited (CONCORDBIO) is broadly categorized in Miscellaneous segment industry which deals in Biotechnology & Medical Research vertical.
It is one of Small Cap company with Market Capitalization of Rs 0 (in Cr). Total number of free float shares are 0 (in Lacs).
Concord Biotech Limited is listed on NSE with Exchange ID - INE338H01029 and trading code is NSE:CONCORDBIO with short name Concord Biotech.
In the past 1 year, Concord Biotech Limited has declared an equity dividend of Rs 0.61 per share. At the current share price of CONCORDBIO at Rs 1229.30, this results in a dividend yield of 0.05 %.
As per the Fundamental Analysis of NSE:CONCORDBIO, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine CONCORDBIO underlying value and future prospects. All of this data is available in CONCORDBIO financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:CONCORDBIO, it is clearly understood that CONCORDBIO is Economical performer in terms of earnings and profit margins with an EPS of 32.28. NSE:CONCORDBIO book value per share as of today is 198.91. The current price to book ratio for CONCORDBIO as of Oct 23, 2026 is 6.18.
Valuation of the Stock: The current valuation of CONCORDBIO stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of CONCORDBIO whether to BUY this stock at current valuation. The delivery percentage of CONCORDBIO is 36413% is very crucial parameter which shows that 36413% investors are anticipating that the price of CONCORDBIO share should go up with VWAP at 1246.1.
Now, the main question is whether to BUY or SELL, NSE:CONCORDBIO at current valuation.
As per latest Analysis No. #3194:-
⇑ STRONG BUY CONCORDBIO if All Greens
⇗ BUY CONCORDBIO (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD CONCORDBIO (With Stop Loss) if only 1 Green
⇘ SELL CONCORDBIO if NO Green Indicator
NSE: CONCORDBIO Share Price Today (Oct 23, 2026)
(Concord Biotech Limited Daily Analysis on the basis of CONCORDBIO Intraday Graph & Trend)
Concord Biotech Limited share price moved Down by -3.26% from its previous close of Rs 1270.7. CONCORDBIO stock last traded price is 1229.30. CONCORDBIO share price trend is Down with a total of 96706 stocks traded till now. It has touched an intraday high of Rs 1279.7 and an intraday low of Rs 1212.5. The CONCORDBIO trading at 1229.30, Down by Rs. -41.40, or -3.26 percent which suggests that most of the Traders are anticipating that the price of CONCORDBIO share should go Down.
NSE: CONCORDBIO Share Price Tomorrow Prediction
(Concord Biotech Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of CONCORDBIO)
Concord Biotech Limited share price moved Down by -3.26%. CONCORDBIO share price short term trend is Down. It suggests that CONCORDBIO Share Price for Tomorrow remains the same with VWAP at 1246.1 will be treated as stop loss for intraday traders. Concord Biotech Limited Long term investors can follow the CONCORDBIO long term trend as mentiond in future forecast table.
NSE Code |
NSE: CONCORDBIO |
CONCORDBIO Share Price Today |
1229.30 |
CONCORDBIO Share Price Target Prediction for 2026 ^ |
1034.8 - 1381.1 |
CONCORDBIO Share Price Target Prediction for 2027*^ |
1381.1 - 1729 |
CONCORDBIO Share Price Target Prediction for 2028*^ |
1729 - 1850 |
CONCORDBIO Share Price Target Prediction for 2029*^ |
1943 |
CONCORDBIO Share Price Target Prediction for 2030*^ |
1998 |
CONCORDBIO Share Price Target Prediction for 2035*^ |
2178 |
| CONCORDBIO Current Book Value |
197.9 |
*Concord Biotech Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^CONCORDBIO share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
CONCORDBIO Technical Analysis
Candlestick Pattern: @1464.5| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 1448.6 | BUY | 1458.03 | BUY |
| MA_12 | 1477.75 | SELL | 1467.42 | SELL |
| MA_20 | 1496.64 | SELL | 1463.83 | BUY |
| MA_32 | 1441.97 | BUY | 1440.09 | BUY |
| MA_50 | 1398.75 | BUY | 1409.1 | BUY |
| MA_100 | 1320.67 | BUY | 1355.42 | BUY |
| MA_200 | 1266.33 | BUY | 1354.67 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 1496.64 | Downtrend |
| MACD | -12.89 | SELL |
| ADX | 19.95 | NO or Weak Trend |
| DMI (+/-) | 20.67 / 17.91 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 51.87 | Neutral |
| STOCHASTIC_K (Fast) | 68.84 | Neutral |
| STOCHASTIC_D (Slow) | 53.31 | Neutral |
| CCI | -43.34 | Neutral |
| PSAR | 1530.53 | SELL |
| TRUE RANGE | 32.2 | BUY |
| ATR | 48.58 | BUY |
| WILLIAMS R | -70.18 | Neutral |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 88.28 | Overbought |
| STOCHASTIC RSI D | 76.85 | Neutral |
| MOMENTUM | 35.6 | BUY |
| Duration | Value |
|---|---|
| 1 Year | -12.24% |
| 3 Months | 15.12% |
| 1 Month | 2.49% |
| 1 Week | 1.36% |
| Action | Overall (%) |
|---|---|
| BUY | 53% |
| NEUTRAL / HOLD | 27% |
| SELL | 20% |
(powered by Zerodha)
Most popular Questions & Answers about CONCORDBIO
Concord Biotech Limited Frequently Asked Questions (FAQs)Concord Biotech Limited stock last traded price is 1229.30. CONCORDBIO share price moved Down by -3.26% from its previous close of Rs 1270.7.
Concord Biotech Limited share price trend is Down with a total of 96706 stocks traded till now. It has touched an intraday high of Rs 1631.15 and an intraday low of Rs 1212.5. The CONCORDBIO trading at 1229.30, Down by Rs. -41.40, or -3.26 percent which suggests that most of the Traders are anticipating that the price of CONCORDBIO share should go Down and the Stop Loss will be around 1246.1.
The market cap of Concord Biotech Limited is ₹0 (in Cr) as of Oct 22, 2026.
The current price to earning ratio for Concord Biotech Limited as of Oct 22, 2026 is 45.61.
The current price to book ratio for Concord Biotech Limited as of Oct 22, 2026 is 6.18.
The highest price of Concord Biotech Limited stock is ₹1615 in the last 52-week.
The lowest price of Concord Biotech Limited stock is ₹987 in the last 52-week.
Concord Biotech Limited share trading at ₹1229.30, Down by Rs. -41.40, or -3.26 percent which suggests that most of the traders are anticipating that the price of CONCORDBIO share should go Down.
In 2026, Stock price target for Concord Biotech Limited (CONCORDBIO) will be around ₹1034.8 on downside and ₹1381.1 on upside. Concord Biotech Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Concord Biotech Limited (CONCORDBIO) will be around ₹1381.1 on downside and ₹1729 on upside. Concord Biotech Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Concord Biotech Limited (CONCORDBIO) will be around ₹1729 on downside and ₹1850 on upside. Concord Biotech Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Concord Biotech Limited (CONCORDBIO) will be around ₹1998 Concord Biotech Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of CONCORDBIO.
The price of Concord Biotech Limited (CONCORDBIO) shares moved by -3.26%. The short-term trend for CONCORDBIO share price is Down. It implies that the share price of CONCORDBIO will stay the same tomorrow and that intraday traders should treat VWAP at 1246.1 as a stop loss. Investors with a long-term outlook can track CONCORDBIO long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of CONCORDBIO stock is 387. Compared to the current market price of 1229.30 INR, the CONCORDBIO stock is Overvalued by 68.5%.
As per the fundamental analysis of Concord Biotech Limited (CONCORDBIO), it is of Economical quality in terms of earnings and profit margins with an EPS of 32.28. Concord Biotech Limited book value per share as of today is 198.91. The current price to book ratio for CONCORDBIO as of Oct 23, 2026 is 6.18.
NSE:CONCORDBIO News & Other Useful Information about CONCORDBIO Share Price
Peer Comparison of NSE: CONCORDBIO
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Biotechnology & Medical Research
| Company | Price | EPS | BV |
|---|---|---|---|
| WINDLAS | 872.70 | 46.21 | 285.12 |
| ARVEE | 165.00 | 3.68 | 32.2 |
| CONCORDBIO | 1229.30 | 32.28 | 198.91 |